Medicare Enrolled
Dr. Babak Bamshad, M.D.
Pediatric Urology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bamshad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bamshad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bamshad
Dr. Babak Bamshad is a pediatric urology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bamshad performed 15,600 Medicare services across 6,882 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bamshad received a total of $4,372 from 29 pharmaceutical and/or device companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bamshad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in CA
$4,372 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,600
Medicare services
Top 11% in CA for pediatric urology physician
6,882
Unique beneficiaries
$113
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~821 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
2,687 | $10 | $150 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
2,465 | $4 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,467 | $104 | $358 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,117 | $150 | $464 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
916 | $66 | $165 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
862 | $68 | $252 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
731 | $118 | $150 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
698 | $53 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
585 | $100 | $222 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
578 | $660 | $2,500 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
479 | $8 | $15 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
399 | $82 | $105 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
398 | $627 | $2,500 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
312 | $62 | $228 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
271 | $294 | $850 |
| Bladder stone removal, less than 2.5 cm A procedure to crush, fragment, and remove bladder stones that are smaller than 2.5 centimeters. |
253 | $802 | $2,500 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 187 | $136 | $650 |
| Testosterone enanthate injection An injection of testosterone enanthate, a form of testosterone hormone. The dose is measured in milligrams. |
179 | $0 | $40 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
156 | $31 | $100 |
| Urethral stricture dilation, subsequent A procedure to widen a narrowed urethra in males using a dilator. This is a follow-up treatment for a previously treated stricture. |
142 | $52 | $100 |
| New patient office visit, complex (60-74 min) | 140 | $186 | $680 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
134 | $145 | $560 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $140 | $540 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
86 | $44 | $165 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
71 | $130 | $441 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
66 | $109 | $445 |
| Complicated insertion of bladder tube | 54 | $132 | $423 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
18 | $196 | $250 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
18 | $52 | $350 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
14 | $56 | $385 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $90 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,372
Total received (2018-2024)
Avg $625/year across 7 years
Top 30% in CA for pediatric urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
173
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,989 (91.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$383 (8.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$360
2023
$1,123
2022
$979
2021
$647
2020
$226
2019
$330
2018
$708
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Myriad Genetic Laboratories, Inc.
$141
PFIZER INC.
$84
Astellas Pharma US Inc
$33
180 Medical, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
Endo Pharmaceuticals Inc.
$26
Sumitomo Pharma America, Inc.
$20
Top 3 companies account for 71.7% of 2024 payments
All-time payments by company (2018-2024) ›
Myriad Genetic Laboratories, Inc.
$940
PFIZER INC.
$763
Astellas Pharma US Inc
$708
Teleflex LLC
$284
Endo Pharmaceuticals Inc.
$231
UroGen Pharma, Inc.
$206
Boston Scientific Corporation
$186
Acerus Pharmaceuticals Corporation
$130
Janssen Biotech, Inc.
$123
Myovant Sciences Inc.
$110
Blue Earth Diagnostics Limited
$102
Janssen Products, LP
$61
Amgen Inc.
$60
Sumitomo Pharma America, Inc.
$50
TOLMAR Pharmaceuticals, Inc.
$49
AbbVie Inc.
$46
Avadel Specialty Pharmaceuticals, LLC
$44
UROGEN PHARMA, INC.
$34
IsoRay, Inc
$29
180 Medical, Inc.
$29
Bayer Healthcare Pharmaceuticals Inc.
$28
UROVANT SCIENCES INC
$25
Merck Sharp & Dohme LLC
$25
Alexion Pharmaceuticals, Inc.
$24
ConvaTec Inc.
$22
Tolmar, Inc.
$19
Accord Healthcare, Inc.
$16
Antares Pharma, Inc.
$15
ABBVIE INC.
$13
Top 3 companies account for 55.2% of all-time payments
Associated products mentioned in payments ›
AVEED · Axumin · Brachytherapy Source · CAMCEVI · ELIGARD · ERLEADA · EVENITY · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · GentleCath · JELMYTO · KEYTRUDA · LUPRON DEPOT · MYRBETRIQ · MYRISK · Myrbetriq · Natesto · Noctiva · Nubeqa · ORGOVYX · PAXLOVID · PROLARIS · Prolaris · Prolia · STRENSIQ · TOVIAZ · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pediatric urology physicians within 10 mi
12
Per 100K population
0.1
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bamshad is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bamshad experienced with bladder ultrasound after voiding?
Based on Medicare claims data, Dr. Bamshad performed 2,687 bladder ultrasound after voiding services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bamshad receive payments from pharmaceutical companies?
Yes. Dr. Bamshad received a total of $4,372 from 29 companies across 173 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bamshad's costs compare to other pediatric urology physicians in Los Angeles?
Dr. Bamshad's average Medicare payment per service is $113. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bamshad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pediatric Urology Physicians in Los Angeles
Browse pediatric urology physicians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Urology Physicians in CA
Pediatric urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Urology Physicians in CA
Which CA pediatric urology physicians receive the most from drug and device companies.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology